Skip to content. | Skip to navigation

Personal tools

David Kroeger, PhD


 Peer-Reviewed Papers



  •  Wick DA, Webb JR, Nielsen JS, Martin SD, Kroeger DR, Milne K, Castellarin M,Twumasi-Boateng K, Watson PH, Holt RA, Nelson BH. Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer. Clin Cancer Res. 2014 Mar 1;20(5):1125-34. doi: 10.1158/1078-0432.CCR-13-2147.Epub 2013 Dec 9. [PubMed - 24323902]



  •   David R. Kroeger, Christopher D. Rudulier and Peter A. Bretscher. Antigen Presenting B cells Facilitate CD4 T Cell Cooperation Resulting in Enhanced Generation of Effector and Memory CD4 T cells. Submitted May 2012.
  • Christopher D. Rudulier, David R. Kroeger, Peter A. Bretscher. Antigen-mediated interactions between CD4 T cells control their Th1/Th2 differentiation. Submitted May 2012.

  •  David R. Kroeger, Christopher D. Rudulier, Nathan C. Peters, and Peter A. Bretscher (2012). Direct Demonstration of CD4 T Cell Cooperation in the Primary Generation of CD4 Effector T cells. International Immunology. ePub April 22, 2012.  [PubMed - 22527289]

  •  Christopher D. Rudulier, David R. Kroeger, Peter A. Bretscher (2012). On the Distinct Roles of Dendritic and B cells in the Activation of Naive CD4 T cells. Immunotherapy 4 (4) 355-357.   [PubMed - 22512626]

  • Christopher D. Rudulier, David R. Kroeger, and Peter A. Bretscher (2012). The activation, by antigen, of naïve TCR transgenic CD4 T cells cultured at physiological, rather than artificially high, frequencies more accurately reflects the in vivo activation of normal numbers of naïve CD4+ T cells. Cellular Immunology 274 (1-2) 115-120. [PubMed - 22370222]



  •  Nathan C. Peters, David R. Kroeger, Steven Mickelwright and Peter A. Bretscher (2009). CD4 T cell cooperation is required for the in vivo activation of CD4 T cells. International Immunology. 21:1213-1224. [PubMed - 19736293]
  •  Duane Hamilton, Nahed Ismail, David Kroeger, Christopher Rudulier, and Peter Bretscher (2009). Macroimmunology and Immunotherapy of Cancer. Immunotherapy. Vol 1, 3: 367-383.